{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T14:05:55Z","timestamp":1775052355822,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jiac.2021.01.006","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T21:24:21Z","timestamp":1611005061000},"page":"808-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6929-8955","authenticated-orcid":false,"given":"Satoshi","family":"Kutsuna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5171-1828","authenticated-orcid":false,"given":"Mari","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Miyazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takato","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maeda","family":"Kenji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9595-9657","authenticated-orcid":false,"given":"Masayuki","family":"Hojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihito","family":"Ishizaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"382","key":"10.1016\/j.jiac.2021.01.006_bib1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"26","author":"Li","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2021.01.006_bib2","series-title":"Coronavirus disease (COVID-19) Situation Report \u2013199","year":"2020"},{"key":"10.1016\/j.jiac.2021.01.006_bib3","article-title":"Antibody detection and dynamic characteristics in patients with COVID-19","author":"Xiang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.01.006_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jiac.2021.01.006_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of COVID-19 \u2014 preliminary report","author":"Beigel","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2021.01.006_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.35772\/ghm.2020.01034","article-title":"Major ongoing clinical trials for COVID-19 treatment and studies currently being conducted or scheduled in Japan","volume":"2","author":"Ito","year":"2020","journal-title":"Global Health Med"},{"key":"10.1016\/j.jiac.2021.01.006_bib7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/trf.15843","article-title":"Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design","volume":"60","author":"Barone","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.jiac.2021.01.006_bib8","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2021.01.006_bib9","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.jiac.2021.01.006_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2021.01.006_bib11","first-page":"2020","article-title":"Treatment of COVID-19 patients with convalescent plasma in Houston, Texas","author":"Salazar","year":"2020","journal-title":"Preprint. medRxiv"},{"key":"10.1016\/j.jiac.2021.01.006_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2020.03.039","article-title":"Treatment with convalescent plasma for critically ill patients with severe acute respiratory syndrome coronavirus 2 infection","volume":"158","author":"Zhang","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2021.01.006_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25882","article-title":"Treatment with convalescent plasma for COVID-19 patients in Wuhan, China","author":"Ye","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jiac.2021.01.006_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/infdis\/jiaa228","article-title":"Effect of convalescent plasma therapy on viral shedding and survival in COVID-19 patients","volume":"222","author":"Zeng","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2021.01.006_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.it.2020.03.007","article-title":"Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses","volume":"41","author":"Jiang","year":"2020","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jiac.2021.01.006_bib16","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3201\/eid2607.200841","article-title":"Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients","volume":"26","author":"Okba","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2021.01.006_bib17","first-page":"20047365","article-title":"Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications","author":"Wu","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.jiac.2021.01.006_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jiac.2021.01.006_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jiac.2021.01.006_bib20","article-title":"Loss of anti\u2013SARS-CoV-2 antibodies in mild covid-19","volume":"383","author":"Kutsuna","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2021.01.006_bib21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jiac.2021.01.006_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.01.006_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","volume":"20","author":"To","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2021.01.006_bib24","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2021.01.006_bib25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nrrheum.2011.37","article-title":"C-reactive protein in rheumatology: biology and genetics","volume":"7","author":"Rhodes","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jiac.2021.01.006_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2021.01.006_bib27","first-page":"1","article-title":"Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study","author":"Sun","year":"2020","journal-title":"World J Pediatr"},{"key":"10.1016\/j.jiac.2021.01.006_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cid\/ciaa272","article-title":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China","volume":"71","author":"Wang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.01.006_bib29","article-title":"A\u00a0comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex","author":"Zeng","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jiac.2021.01.006_bib30","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2021.01.006_bib31","first-page":"1775","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","volume":"323","author":"Onder","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2021.01.006_bib32","doi-asserted-by":"crossref","first-page":"m1091","DOI":"10.1136\/bmj.m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jiac.2021.01.006_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21688","article-title":"Androgen sensitivity gateway to COVID-19 disease severity","author":"Wambier","year":"2020","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.jiac.2021.01.006_bib34","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jocd.13443","article-title":"A\u00a0preliminary observation: male pattern hair loss among hospitalized COVID-19 patients in Spain \u2014 a potential clue to the role of androgens in COVID-19 severity","volume":"19","author":"Goren","year":"2020","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"83","key":"10.1016\/j.jiac.2021.01.006_bib35","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaad.2020.05.079","article-title":"Androgenetic alopecia present in the majority of hospitalized COVID-19 patients - the \"Gabrin sign\"","volume":"21","author":"Wambier","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21000143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21000143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:02:04Z","timestamp":1761159724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21000143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1341321X21000143"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.01.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}